Tag: obligation

Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) for a Phase 1 clinical study of ORX142 in healthy volunteers. (click here).

PRESS RELEASE

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against KBR, Inc. (“KBR” or the “Company”) (NYSE:KBR) on behalf of KBR stockholders. Our investigation concerns whether KBR has violated the federal securities laws and/or engaged in other unlawful business practices.

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

TORONTO, July 03, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) provides the following update regarding the management cease trade order (“MCTO”) issued by the British Columbia Securities Commission (“BCSC”) on May 1, 2025, under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).